Home / News / Event #1115965 SEC EDGAR published this disclosure on 2026-09-09. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗ accession 0001193125-26-386794
acquired disposed D
code S
direct or indirect D
form 4
is derivative false
issuer name BELITE BIO, INC
label Open market sale
Source record & verification Dates, provenance and technical details
Context links are based on the recorded entity type Recorded payload Structured source data
Recorded payload JSON payload as stored after parsing {
"accession": "0001193125-26-386794",
"acquired_disposed": "D",
"code": "S",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "BELITE BIO, INC",
"label": "Open market sale",
"person_name": "Lin Yu-Hsin",
"price": 187.2523,
"role": "Director, Chief Executive Officer",
"security": "American depositary share",
"shares": 6200,
"shares_owned_after": 132134,
"source_path": "edgar/data/1889109/0001193125-26-386794.txt",
"ticker": "BLTE",
"transaction_date": "2026-09-04",
"value": 1160964.26
}
Evidence-based analysis facts, provenance and explicit model coverage Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.